Bringing Cure...Building Hope...
Home | Blog | Events
Pharma legitimate consultant and facilitator in Delhi India

Oncology Drugs Approved For soft-tissue sarcoma by US FDA

IPN, New Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. IPN can facilitate patient to import of "Bladder Anti-Cancer Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Get Access to FDA Approved Drugs / Anti-Cancer Medicines
For soft-tissue sarcoma Treatment in India

A soft-tissue sarcoma (STS) is a malignant tumour, a type of cancer, that develops in soft tissue.[1] A soft tissue sarcoma is often a painless mass that grows slowly over months or years. They may be superficial or deep-seated. Any such unexplained mass must be diagnosed by biopsy.\Treatment may include, surgery, radiotherapy, chemotherapy, and targeted drug therapy.[3] The other type of sarcoma is a bone sarcoma.

In their early stages, soft-tissue sarcomas usually do not cause symptoms. Because soft tissue is relatively elastic, tumors can grow rather large, pushing aside normal tissue, before they are felt or cause any problems. The first noticeable symptom is usually a painless lump or swelling. As the tumor grows, it may cause other symptoms, such as pain or soreness, as it presses against nearby nerves and muscles. If in the abdomen it can cause abdominal pains commonly mistaken for menstrual cramps, indigestion, or cause constipation.

The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for soft-tissue sarcoma treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

LARTRUVO

LARTRUVO (olaratumab) injection, for intravenous use Initial U.S. Approval: 2016. Lartruvo (olaratumab) in combination with doxorubicin is indicated for the treatment of soft tissue sarcoma (STS) in adult patients. The drug is available as a 10mg/ml injection.

More Details...
GLEEVEC

GLEEVEC (imatinib mesylate) tablets for oral use Initial U.S. Approval: 2001. GLEEVEC (imatinib mesylate) is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It works by slowing or stopping the growth of cancer cells.

More Details...
HALAVEN

HALAVEN (eribulin mesylate) Injection For intravenous administration only. Eisai Inc. Initial US Approval: 2010. HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.

More Details...
YONDELIS

YONDELIS (trabectedin) for injection, for intravenous use Initial U.S. Approval: 2015. YONDELIS is a prescription medicine used to treat people with liposarcoma or leiomyosarcoma that cannot be treated with surgery or has spread to other areas of the body, and who have received treatment with certain other medicines.

More Details...
VOTRIENT

VOTRIENT (pazopanib) tablets Initial U.S. Approval: 2009. VOTRIENT (pazopanib) tablets is a prescription medicine used to treat adults with advanced renal cell cancer (RCC). VOTRIENT is a prescription medicine used to treat adults with advanced soft tissue sarcoma (STS) who have received chemotherapy in the past.

More Details...
TAZVERIK

TAZVERIK (tazemetostat) tablets, for oral use Initial U.S. Approval: 2020. T AZVERIK is indicated for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least 2 prior systemic therapies.

More Details...

Your Query Form

Head Office

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi, New Delhi:110016 India.

Mobile / WhatsApp Number:
Mobile: +91-9891296838 / 9811747774
WhatsApp: +91-9891296838 / 9811747774

Contact Details:
Phone: +91-11-26532129 / 26536398
Fax: +91-11-26532129 / 26536398

E Mail:
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Social Media:
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved soft-tissue sarcoma medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of soft-tissue sarcoma Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

If you have a question relating to anti-cancer medicines approved for treatment of soft-tissue sarcoma, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Indian Pharma Network, New Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals.
Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Mumbai | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur | Punjab | Chandigarh
Our Overseas Network Uk | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa